Back
PAVmed Vs. Criteo SA Industry Stock Comparison
Sell
15
PAVM
PAVmed
Last Price:
1.05
Seasonality Move:
-28.3%
Sell
2
CRTO
Criteo SA
Last Price:
33.70
Seasonality Move:
3.01%
Sell
15
PAVmed (PAVM)
is a Sell
Is PAVmed a Buy, Sell or Hold?
- The current PAVmed [PAVM] share price is $1.06. The Score for PAVM is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- PAVM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
2
Criteo SA (CRTO)
is a Sell
Is Criteo SA a Buy, Sell or Hold?
- The current Criteo SA [CRTO] share price is $33.72. The Score for CRTO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- CRTO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PAVM Stock Price Chart
PAVM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 44.32 | Sell |
Chaikin Money Flow: | -14582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.05 - 1.23) | Sell |
Bollinger Bands (100): | (0.76 - 1.3) | Buy |
CRTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.76 | Sell |
Relative Strength Index (14 RSI): | 27.62 | Sell |
Chaikin Money Flow: | -1514757 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.73 - 42.13) | Sell |
Bollinger Bands (100): | (38.3 - 45.96) | Sell |
PAVM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.07 | Sell |
20-day SMA: | 1.13 | Sell |
50-day SMA: | 1.18 | Sell |
200-day SMA: | 1.56 | Sell |
8-day EMA: | 1.08 | Sell |
20-day EMA: | 1.12 | Sell |
50-day EMA: | 1.15 | Sell |
200-day EMA: | 1.83 | Sell |
CRTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.46 | Sell |
20-day SMA: | 40.42 | Sell |
50-day SMA: | 42.75 | Sell |
200-day SMA: | 37.87 | Sell |
8-day EMA: | 39.74 | Sell |
20-day EMA: | 40.61 | Sell |
50-day EMA: | 41.67 | Sell |
200-day EMA: | 38.56 | Sell |
PAVmed Earnings Growth & PAVM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $0.16 per share.
Criteo SA Earnings Growth & CRTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.63 per share, and an increase next year of $0.00 per share.
PAVmed Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Criteo SA Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |